SANUWAVE Health, Inc. Common Stock (SNWV) — 分析摘要
SANUWAVE Health, Inc. Common Stock(SNWV)的市值为50.99百万美元,最近一年的营收同比增长了+36.3%。净利润率为26.8%。当前市盈率为3.2倍。
核心要点
- 营收同比变化+36.3%
- 净利润率26.8%
- 市盈率3.2倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,SNWV的营收增长为+36.3%,市盈率为3.2倍。
SANUWAVE Health, Inc. Common Stock (SNWV)
更新 — ET · 来源 POLYGON
红旗与风险提示高风险信号
存在多项实质性红旗,在依赖任何估值输出前应先重点核查这些风险。
D/E 为 11.2x — 杠杆极高
Debt/EBITDA 为 5.3x — 杠杆偏高
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
55
总部
EDEN PRAIRIE, MN
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。